Close Menu
Home › Qiagen, DiaSorin Partner to Automate Latent TB Testing

Qiagen, DiaSorin Partner to Automate Latent TB Testing

Jan 08, 2018

NEW YORK (360Dx) – Qiagen and DiaSorin announced today that they are working together to pair Qiagen's QuantiFeron-TB diagnostic test with DiaSorin's Liaison family of automated analyzers.

Customers of both companies will now be able to process Qiagen's QuantiFeron-TB Gold Plus (QFT-Plus) assay for latent tuberculosis detection on DiaSorin Liaison platforms, in addition to the standard current workflow. The companies noted that there are more than 7,000 Liaison systems in laboratories worldwide.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
27
Featured Webinar

How One NGS Core Lab Reduced Sequencing Costs with a Novel Library Normalization Kit

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Apr
09
Featured Webinar

Combining AI with Community-Driven Insights: Advanced Diagnosis of Inherited Cardiac Diseases

Sponsored by
Sophia Genetics

This webinar will present the utility of a personalized in silico analytical approach for the routine clinical diagnosis of channelopathies and cardiomyopathies. 

What's Popular?

In Infectious Disease

  1. Abbott Receives CE Mark for Alinity Molecular Diagnostics System, Assays

  2. TGen Inks Tuberculosis Test Deal With Advanced Biological Laboratories

  3. SpeeDx Signs Distributor Deals in Middle East

  4. Molecular Macrolide Resistance Assay Shows Promise for Point-of-Care Use

    Premium

  5. AusDiagnostics Inks Four European Distribution Deals

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.